US Treasury tries to soothe the bond market
· Summarized
Key takeaways
- The US Treasury is taking unconventional steps, like buying more long-term debt, to stabilize the bond market amid inflation fears and high debt levels.
- Moderna's success with a personalized cancer vaccine illustrates the transformative potential of mRNA technology beyond COVID-19, boosting investor confidence in the biotech sector.
- The early hiring practices by top US law firms respond to technological changes and talent competition but have raised concerns about increased pressure on students and potential impacts on the legal profession's future.
- Ireland's traditional pub industry faces decline due to economic and social challenges, with efforts underway to protect its cultural significance.
Summary
US Treasury's Intervention in the Bond Market
The US Treasury is actively trying to calm the recent bond sell-off caused by fears around inflation and rising borrowing costs. By announcing plans to double its purchases of long-term government debt, the Treasury hopes to influence the bond market positively. Early reactions were optimistic, with a temporary decrease in borrowing costs. However, the effectiveness remains uncertain, especially after a modest response to a recent bond auction. The broader challenges include persistent inflation concerns voiced by members of the Federal Reserve and the enormous US debt level crossing $40 trillion. While bond buying may offer some relief, it won't fully address underlying fiscal and geopolitical issues impacting the market.
Moderna's Breakthrough with Cancer Vaccine and Stock Surge
Moderna's shares soared by 177% following promising trial results for a groundbreaking personalized skin cancer vaccine that uses mRNA technology similar to its COVID-19 vaccines. This innovative treatment is tailored to individual tumors, representing a significant advancement in cancer therapy. Despite declines in demand post-pandemic, the company's success in this trial has reinvigorated investor confidence and marked a potential new chapter for Moderna as a leader in personalized medicine.
Controversy in Legal Industry Due to Early Recruitment Practices
Top US law firms are increasingly hiring first-year law students earlier in their studies, a shift driven by fierce competition for talent and the growing importance of human skills in an AI-augmented legal landscape. This practice is controversial because it puts considerable pressure on students immediately upon starting law school, exacerbating stress and anxiety, especially among those from less privileged backgrounds. Critics argue that this early recruitment might lead to less qualified applicants and undermine the traditional legal training process, raising questions about the future of legal employment and the impact of AI on legal work.
Decline of Irish Pubs and Cultural Heritage Concerns
The number of public houses in Ireland has decreased by a quarter in the last two decades, driven by rising costs and shifting social habits. Industry groups are urging the government for tax breaks and policies to preserve these historic establishments, which are integral to Irish culture. Efforts to have UNESCO recognize pubs as part of Ireland's cultural heritage have so far been unsuccessful, highlighting the challenges faced by traditional pubs in modern Ireland.
Sponsors
- FT · The FT does not use generative AI to voice its podcasts
Show notes
Shares in vaccine-maker Moderna lept after it reported successful trial results for an experimental cancer vaccine, and the US Treasury department will at least double the size of its buyback of long-term government debt. Plus, top US legal firms are sparking controversy for hiring students in their first few months of law school and Irish pubs are disappearing.
Mentioned in this podcast:
US Treasury to double buybacks of long-term government debt
Moderna shares double on melanoma vaccine trial success
Top US law firms hit by backlash over ‘crazy’ hiring of first-year students
Want to get in touch? Email us at [email protected]
Note: The FT does not use generative AI to voice its podcasts
The FT News Briefing is produced by Victoria Craig, Sonja Hutson, Saffeya Ahmed, and Katya Kumkova. Our editor is Marc Filippino. Our show is mixed by Sam Giovinco and Alex Higgins. Additional help from Gavin Kallmann, Michael Lello, Peter Barber and David da Silva. Our executive producer is Topher Forhecz. Flo Phillips is the FT’s global head of audio. The show’s theme music is by Metaphor Music.
Read a transcript of this episode on FT.com
Hosted on Acast. See acast.com/privacy for more information.
Follow this show on AudioBrevity and new episodes get summarized for you. Create a free account